Highest Score

Ranked by analysis score
Ranks this page's recent reports by score.
Domino's Pizza, Inc.
DPZ·Consumer Discretionary
A ★★★★Buy
Current$305.42
Target$360.00
Return+17.9%
Oct 20, 2026

Domino's combines a globally scaled franchise network, resilient cash generation, and a discounted valuation, but slowing U.S. restaurant demand and substantial financial leverage could delay the earnings recovery.

Score
79
HDFC Bank Limited
HDB·Financials
A ★★★★Buy
Current$23.08
Target$26.22
Return+13.6%
Oct 20, 2026

HDFC Bank offers a durable Indian banking franchise at a discounted valuation with upside from recovering ROE and funding efficiency, although governance uncertainty and persistent margin pressure could delay the recovery.

Score
79
The PNC Financial Services Group, Inc.
PNC·Financials
A ★★★★Buy
Current$217.39
Target$258.00
Return+18.7%
Oct 19, 2026

PNC combines a durable deposit-funded banking franchise, improving earnings, and attractive shareholder distributions at a reasonable valuation, although credit-cycle risk and interest-rate volatility could limit future returns.

Score
79
Nutanix, Inc.
NTNX·Technology
B ★★★Hold
Current$68.88
Target$81.00
Return+17.6%
Aug 29, 2026

Nutanix is a highly profitable, cash-generating tollbooth for the hybrid cloud transition, aggressively stealing market share from VMware, though the lack of an extreme valuation discount and aggressive insider selling warrant a disciplined entry strategy.

Score
79
A10 Networks, Inc.
ATEN·Technology
B ★★★Hold
Current$26.12
Target$38.40
Return+47.0%
Aug 25, 2026

A10 Networks is a highly profitable, cash-gushing tollbooth for the global AI infrastructure buildout, executing flawless margin expansion and capital returns, though investors must remain hyper-vigilant regarding its extreme revenue concentration with Microsoft and historically stretched valuation multiples.

Score
79
Alumis Inc.
ALMS·Healthcare
B ★★★Hold
Current$22.86
Target$35.00
Return+53.1%
Aug 22, 2026

Alumis commands a scientifically supreme oral immunology franchise, yet its multi-billion dollar valuation is tightly checked by relentless cash burn and entrenched competition.

Score
79
National HealthCare Corporation
NHC·Healthcare
B ★★★Hold
Current$234.04
Target$245.00
Return+4.7%
Aug 21, 2026

National HealthCare is an elite, geographically concentrated post-acute compounder brilliantly internalizing its real estate to drive immense free cash flow, though investors must navigate the execution risks of its sudden shift from a debt-free operator to a leveraged owner at peak historical valuations.

Score
79
Kadant Inc.
KAI·Industrials
B ★★★Hold
Current$329.72
Target$361.67
Return+9.7%
Aug 21, 2026

Kadant is a premier, highly defensive industrial compounder operating a lucrative 'razor and blades' model, though investors must exercise patience as the stock currently commands a premium valuation that fully prices in its structural excellence.

Score
79
Otter Tail Corporation
OTTR·Utilities
B ★★★Hold
Current$92.63
Target$100.32
Return+8.3%
Aug 20, 2026

Otter Tail offers investors an incredibly rare, self-funding utility growth engine trading at a deep discount to peers, though near-term headline earnings will remain heavily suppressed by the painful, inevitable deflation of its pandemic-era plastics boom.

Score
79
Comstock Resources, Inc.
CRK·Energy
B ★★★Hold
Current$14.06
Target$15.50
Return+10.2%
Aug 20, 2026

Comstock is executing a masterful operational scale-up in the Haynesville to capture explosive long-term power and LNG demand, yet its heavy reliance on debt and unhedged spot pricing demands extreme patience from investors.

Score
79
The Scotts Miracle-Gro Company
SMG·Materials
B ★★★Hold
Current$60.94
Target$78.00
Return+28.0%
Aug 19, 2026

Stripped of its disastrous hydroponic distractions, Scotts Miracle-Gro is a massively profitable, cash-generating consumer monopoly trading at a historically cheap forward multiple, though investors must remain hyper-vigilant regarding its elevated debt load and the looming threat of class-action litigation.

Score
79
Life360, Inc.
LIF·Technology
B ★★★Hold
Current$51.72
Target$61.48
Return+18.9%
Aug 18, 2026

Life360 is an elite, hyper-growth family safety platform expanding rapidly into digital advertising, though investors must carefully navigate near-term dilution risks from convertible debt and heavy insider selling.

Score
79